UPDATE 3-China's CSPC Pharmaceutical signs deal with AstraZeneca for weight-loss therapy ...Middle East

Devdiscourse - Opinion
AstraZeneca will license experimental drugs for ‌obesity and weight-related conditions from CSPC Pharmaceutical Group and collaborate on additional projects, paying $1.2 billion upfront and up to $17.3 billion more if ⁠development and sales milestones are met, the Chinese drugmaker said on Friday. The deal is the latest tie-up between the two pharmaceutical giants, following collaboration in areas such as artificial intelligence. ​It expands AstraZeneca's investment in the growing obesity market led by Western rivals.

Hence then, the article about update 3 china s cspc pharmaceutical signs deal with astrazeneca for weight loss therapy was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( UPDATE 3-China's CSPC Pharmaceutical signs deal with AstraZeneca for weight-loss therapy )

Apple Storegoogle play

Last updated :

Also on site :